The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells

Pollard, 2013, Interferon-γ and systemic autoimmunity, Discov Med, 16, 123 Baeck, 2018, Increased expression of interleukin-9 in patients with allergic contact dermatitis caused by p-phenylenediamine, Contact Dermatitis, 79, 346, 10.1111/cod.13123 Jia, 2017, Detection of IL-9 producing T cells in the PBMCs of allergic asthmatic patients, BMC Immunol, 18, 38, 10.1186/s12865-017-0220-1 Clark, 2017, T(H)9 cells in skin disorders, Semin Immunopathol, 39, 47, 10.1007/s00281-016-0607-8 Tabarkiewicz, 2015, The role of IL-17 and Th17 lymphocytes in autoimmune diseases, Arch Immunol Ther Exp (Warsz), 63, 435, 10.1007/s00005-015-0344-z Spence, 2015, Targeting Treg signaling for the treatment of autoimmune diseases, Curr Opin Immunol, 37, 11, 10.1016/j.coi.2015.09.002 Atwa, 2014, Serum concentration of IL-17, IL-23 and TNF-α among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test, J Eur Acad Dermatol Venereol, 28, 469, 10.1111/jdv.12124 Davoine, 2014, Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity, Front Immunol, 5, 570, 10.3389/fimmu.2014.00570 Jones, 2018, IL-6: a cytokine at the crossroads of autoimmunity, Curr Opin Immunol, 55, 9, 10.1016/j.coi.2018.09.002 Desai, 2016, IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3, J Allergy Clin Immunol, 137, 1863, 10.1016/j.jaci.2015.09.059 Halova, 2012, Mast cell chemotaxis—chemoattractants and signaling pathways, Front Immunol, 3, 119, 10.3389/fimmu.2012.00119 Cop, 2018, Influence of IL-6, IL-33, and TNF-alpha on human mast cell activation: lessons from single cell analysis by flow cytometry, Cytometry B Clin Cytom, 94, 405, 10.1002/cyto.b.21547 Maged Amin, 2018, Hyperlipidemia in association with pro-inflammatory cytokines among chronic spontaneous urticaria: case-control study, Eur Ann Allergy Clin Immunol, 50, 254, 10.23822/EurAnnACI.1764-1489.68 Chen, 2018, Different expression patterns of plasma Th1-, Th2-, Th17-, and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria, J Eur Acad Dermatol Venereol, 32, 441, 10.1111/jdv.14541 Alasandagutti, 2014, Role of IFN-gamma and IL-6 cytokines and their association in determining susceptibility to chronic idiopathic urticaria, Genet Test Mol Biomarkers, 18, 804, 10.1089/gtmb.2014.0193 dos Santos, 2008, Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria, Int Immunopharmacol, 8, 1433, 10.1016/j.intimp.2008.05.016 Kasperska-Zajac, 2015, IL-6 transsignaling in patients with chronic spontaneous urticaria, PLoS One, 10, e0145751, 10.1371/journal.pone.0145751 Kasperska-Zajac, 2011, Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients, Clin Exp Allergy, 41, 1386, 10.1111/j.1365-2222.2011.03789.x Ucmak, 2013, Determination of dermatology life quality index, and serum C-reactive protein and plasma interleukin-6 levels in patients with chronic urticaria, Postepy Dermatol Alergol, 30, 146, 10.5114/pdia.2013.35615 Grzanka, 2018, Interplay between acute phase response and coagulation/fibrinolysis in chronic spontaneous urticaria, Allergy Asthma Clin Immunol, 14, 27, 10.1186/s13223-018-0255-8 Grzanka, 2015, Systemic inflammatory response and calcification markers in patients with long lasting moderate-severe chronic spontaneous urticaria, Eur J Dermatol, 25, 26, 10.1684/ejd.2014.2474 Rajappa, 2013, Platelet oxidative stress and systemic inflammation in chronic spontaneous urticaria, Clin Chem Lab Med, 51, 1789, 10.1515/cclm-2012-0897 Kasperska-Zajac, 2007, Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria, Cytokine, 39, 142, 10.1016/j.cyto.2007.06.008 Metz, 2013, Histamine, TNF, C5a, IL-6, -9, -18, -31, -33, TSLP, neopterin, and VEGF are not elevated in chronic spontaneous urticaria, J Dermatol Sci, 70, 222, 10.1016/j.jdermsci.2013.03.003 Rasool, 2014, Study of serum interleukin (IL) 18 and IL-6 levels in relation with the clinical disease severity in chronic idiopathic urticaria patients of Kashmir (North India), Asia Pac Allergy, 4, 206, 10.5415/apallergy.2014.4.4.206 Tedeschi, 2007, Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity, Clin Exp Dermatol, 32, 568, 10.1111/j.1365-2230.2007.02450.x Deza, 2018, Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria, J Allergy Clin Immunol Pract, 6, 1108, 10.1016/j.jaip.2018.02.024 Folci, 2018, Cutting edge: biomarkers for chronic spontaneous urticaria, J Immunol Res, 2018, 5615109 Kolkhir, 2016, Potential blood biomarkers in chronic spontaneous urticaria, Clin Exp Allergy, 47, 19, 10.1111/cea.12870 Zheng, 2017, Analysis of the changes in Th9 cells and related cytokines in the peripheral blood of spontaneous urticaria patients, Biomed Rep, 6, 633, 10.3892/br.2017.904 Grzanka, 2019, Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria, Allergy Asthma Clin Immunol, 15, 15, 10.1186/s13223-019-0332-7 Sand, 2013, TNF-alpha inhibitors for chronic urticaria: experience in 20 patients, J Allergy, 130905 Wang, 2016, Elevated plasma level of interferon-lambda1 in chronic spontaneous urticaria: upregulated expression in CD8(+) and epithelial cells and induction of inflammatory cell accumulation, Mediators Inflamm, 2016, 5032051, 10.1155/2016/5032051 Ferrer, 2002, Secretion of cytokines, histamine and leukotrienes in chronic urticaria, Int Arch Allergy Immunol, 129, 254, 10.1159/000066772 Lin, 2017, Increased plasma IL-17, IL-31, and IL-33 levels in chronic spontaneous urticaria, Sci Rep, 7, 17797, 10.1038/s41598-017-18187-z Ochi, 2000, IL-4 and -5 prime human mast cells for different profiles of IgE-dependent cytokine production, Proc Natl Acad Sci USA, 97, 10509, 10.1073/pnas.180318697 Arshi, 2014, Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria, Int J Dermatol, 53, e561, 10.1111/ijd.12630 Chandrashekar, 2014, 25-Hydroxy vitamin D levels in chronic urticaria and its correlation with disease severity from a tertiary care centre in South India, Clin Chem Lab Med, 52, e115, 10.1515/cclm-2013-1014 Grzanka, 2017, The relationship between circulating concentrations of interleukin 17 and C reactive protein in chronic spontaneous urticaria, Allergy Asthma Clin Immunol, 13, 25, 10.1186/s13223-017-0197-6 Hermans, 2018, The JAK1/JAK2-inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release, Clin Exp Allergy, 48, 1412, 10.1111/cea.13217 Mohamed, 2003, Increased circulating FcepsilonRII-bearing blymphocytes and serum levels of IL-4 in non-autoreactive chronic idiopathic urticaria, Egypt J Immunol, 10, 9 Piconi, 2002, Immune profiles of patients with chronic idiopathic urticaria, Int Arch Allergy Immunol, 128, 59, 10.1159/000058004 Chen, 2018, Decreased interleukin-35 serum levels in patients with chronic spontaneous urticaria, Ann Allergy Asthma Immunol, 121, 503, 10.1016/j.anai.2018.06.002 Ciprandi, 2012, Serum IL-9 levels in patients with spontaneous urticaria: a preliminary study, J Investig Allergol Clin Immunol, 22, 232 Huilan, 2010, Role of the subgroups of T, B, natural killer lymphocyte and serum levels of interleukin-15, interleukin-21 and immunoglobulin E in the pathogenesis of urticaria, J Dermatol, 37, 441, 10.1111/j.1346-8138.2010.00805.x Kasperska-Zajac, 2018, Circulating soluble LIGHT/TNFSF14 is increased and associated with IL-8 concentration in chronic spontaneous urticaria, Int J Immunopathol Pharmacol, 32, 10.1177/2058738418784431 Puxeddu, 2013, Free IL-18 and IL-33 cytokines in chronic spontaneous urticaria, Cytokine, 61, 741, 10.1016/j.cyto.2013.01.015 de Montjoye, 2019, Increased expression of IL-24 in chronic spontaneous urticaria, Allergy, 74, 1811, 10.1111/all.13832 Gimenez-Arnau, 2017, Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement, Allergy, 72, 1778, 10.1111/all.13183 Metz, 2019, Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: a randomized, double-blind, placebo-controlled study, Allergy, 74, 141, 10.1111/all.13547 Illei, 2010, Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study, Arthritis Rheum, 62, 542, 10.1002/art.27221 Klashman, 1991, In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells, Arthritis Rheum, 34, 276, 10.1002/art.1780340305 Ma, 2018, Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: a meta-analysis, Mod Rheumatol, 28, 849, 10.1080/14397595.2017.1416924 Yacoub, 2016, Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis, Biomark Res, 4, 2, 10.1186/s40364-016-0056-5 Dowse, 2017, Beneficial effects of JAK inhibitor therapy in systemic mastocytosis, Br J Haematol, 176, 324, 10.1111/bjh.13951 Hawkes, 2017, Psoriasis pathogenesis and the development of novel targeted immune therapies, J Allergy Clin Immunol, 140, 645, 10.1016/j.jaci.2017.07.004 Toubi, 2020, The emerging role of IL-17 in the immune-pathogenesis of chronic spontaneous urticaria, Immunotargets Ther, 9, 217, 10.2147/ITT.S266410 Sabag, 2020, Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria, Clin Exp Allergy, 50, 799, 10.1111/cea.13616 Nakamura, 2012, Critical role for mast cells in interleukin-1beta-driven skin inflammation associated with an activating mutation in the nlrp3 protein, Immunity, 37, 85, 10.1016/j.immuni.2012.04.013 Lopalco, 2015, Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives, Mediators Inflamm, 2015, 194864, 10.1155/2015/194864 Kragstrup, 2018, The IL-20 cytokine family in rheumatoid arthritis and spondyloarthritis, Front Immunol, 9, 2226, 10.3389/fimmu.2018.02226 Mizoguchi, 2018, Clinical importance of IL-22 cascade in IBD, J Gastroenterol, 53, 465, 10.1007/s00535-017-1401-7 Martin, 2017, Limited presence of IL-22 binding protein, a natural IL-22 inhibitor, strengthens psoriatic skin inflammation, J Immunol, 198, 3671, 10.4049/jimmunol.1700021 Van Belle, 2012, IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice, J Immunol, 188, 462, 10.4049/jimmunol.1102224 Li, 2018, Epigenetic control of IL-23 expression in keratinocytes is important for chronic skin inflammation, Nat Commun, 9, 1420, 10.1038/s41467-018-03704-z de Montjoye, 2019, L-6 and IL-1beta expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria, Allergy, 74, 2522, 10.1111/all.13928 Irinyi, 2002, Cytokine production of CD4+ and CD8+ peripheral T lymphocytes in patients with chronic idiopathic urticaria, Acta Derm Venereol, 82, 249, 10.1080/000155502320323199 Degirmenci, 2017, Analysis of the association of chronic spontaneous urticaria with interlekin-4, -10, transforming growth factor-beta1, interferongamma, interleukin-17A and -23 by autologous serum skin test, Postepy Dermatol Alergol, 34, 70, 10.5114/pdia.2016.57679 Confino-Cohen, 2004, Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria, Cytokine, 27, 74, 10.1016/j.cyto.2004.03.016 Her, 2016, Alterations in immune function with biologic therapies for autoimmune disease, J Allergy Clin Immunol, 137, 19, 10.1016/j.jaci.2015.10.023 Hermes, 1999, Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria, J Allergy Clin Immunol, 103, 307, 10.1016/S0091-6749(99)70506-3 Wilson, 2011, Treatment of refractory chronic urticaria with tumor necrosis factor–alfa inhibitors, J Am Acad Dermatol, 64, 1221, 10.1016/j.jaad.2009.10.043 Bangsgaard, 2017, Treatment of refractory chronic spontaneous urticaria with adalimumab, Acta Derm Venereol, 97, 524, 10.2340/00015555-2573 Ying, 2002, TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction, J Allergy Clin Immunol, 109, 694, 10.1067/mai.2002.123236 Kay, 2015, Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous ('idiopathic') urticaria, Br J Dermatol, 172, 1294, 10.1111/bjd.13621 Gessner, 2005, Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production, J Immunol, 174, 1063, 10.4049/jimmunol.174.2.1063 Punnonen, 1997, The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells, J Allergy Clin Immunol, 100, 792, 10.1016/S0091-6749(97)70276-8 Toru, 1996, Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4, Int Immunol, 8, 1367, 10.1093/intimm/8.9.1367 Bae, 2016, Periostin and interleukin-13 are independently related to chronic spontaneous urticaria, Allergy Asthma Immunol Res, 8, 457, 10.4168/aair.2016.8.5.457 Lee, 2019, Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria, J Allergy Clin Immunol Pract, 7, 1659, 10.1016/j.jaip.2018.11.018 Van Belle, 2019, IL-24 contributes to skin inflammation in para-phenylenediamine-induced contact hypersensitivity, Sci Rep, 9, 1852, 10.1038/s41598-018-38156-4 Fonseca-Camarillo, 2014, Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study, Clin Exp Immunol, 177, 64, 10.1111/cei.12285 Menezes, 2018, Role of MDA-7/IL-24 a multifunction protein in human diseases, Adv Cancer Res, 138, 143, 10.1016/bs.acr.2018.02.005 Schmetzer, 2018, IL-24 is a common and specific autoantigen of IgE in chronic spontaneous urticaria, J Allergy Clin Immunol, 142, 876, 10.1016/j.jaci.2017.10.035 Nakashima, 2018, Interleukin-31 and interleukin-31 receptor: new therapeutic targets for atopic dermatitis, Exp Dermatol, 27, 327, 10.1111/exd.13533 Altrichter, 2016, Successful omalizumab treatment in chronic spontaneous urticaria is associated with lowering of serum IL-31 levels, J Eur Acad Dermatol Venereol, 30, 454, 10.1111/jdv.12831 Ding, 2018, Interleukin-33: its emerging role in allergic diseases, Molecules, 23, 1665, 10.3390/molecules23071665 Sehra, 2015, TH9 cells are required for tissue mast cell accumulation during allergic inflammation, J Allergy Clin Immunol, 136, 433, 10.1016/j.jaci.2015.01.021 Feng, 2020, Role of Il-9 and Il-10 in the pathogenesis of chronic spontaneous urticaria through the JAK7STAT signalling pathway, Cell Biochem Funct, 38, 480, 10.1002/cbf.3481 Sun, 2011, Detection of CD4+ CD25+ FOXP3+ regulatory T cells in peripheral blood of patients with chronic autoimmune urticaria, Australas J Dermatol, 52, e15, 10.1111/j.1440-0960.2010.00658.x Zhu, 2019, Regulatory T-cell levels in systemic lupus erythematosus patients: a meta-analysis, Lupus, 28, 445, 10.1177/0961203319828530 Morita, 2016, The proportion of regulatory T cells in tients with rheumatoid arthritis: a meta-analysis, PLoS One, 11, e0162306, 10.1371/journal.pone.0162306 Hofmann, 2012, Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury, Clin Immunol, 143, 116, 10.1016/j.clim.2012.02.005 Saito, 2007, The presence of common precursor for basophils and eosinophils, Peds Int, 26, 465, 10.1111/j.1442-200X.1984.tb01851.x Derakhshan, 2020, Lineage-specific regulation of inducible and constitutive mast cells in allergic airway inflammation, J Exp Med, 218, e20200321, 10.1084/jem.20200321 Schleimer, 1992, IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1, J Immunol, 148, 1086, 10.4049/jimmunol.148.4.1086 Kuna, 1992, Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils, J Exp Med, 175, 489, 10.1084/jem.175.2.489 Kuna, 1992, RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils, J Immunol, 149, 636, 10.4049/jimmunol.149.2.636 Kuna, 1993, Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family, J Immunol, 150, 1932, 10.4049/jimmunol.150.5.1932 Grattan, 2003, Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity, Clin Exp Allergy, 33, 337, 10.1046/j.1365-2222.2003.01589.x Oliver, 2015, Interval shifts in basophil measures correlate with disease activity in chronic spontaneous urticaria, Allergy, 70, 601, 10.1111/all.12578 Huang, 2020, Association of basophil parameters with disease severity and duration in chronic spontaneous urticaria (CSU), J Allergy Clin Immunol, 8, 793 Kern, 1976, Defective histamine release in chronic urticaria, J Clin Invest, 57, 1369, 10.1172/JCI108405 Kleine-Tebbe, 2006, Diagnostic tests based on human basophils: potentials, pitfalls and perspectives, Int Archives Allergy Immunol, 141, 79, 10.1159/000094495 Vonakis, 2007, Basophil FcepsilonRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria, J Allergy Clin Immunol, 119, 441, 10.1016/j.jaci.2006.09.035 Oliver, 2016, Altered expression of chemoattractant receptor-homologous molecule expressed on T(H)2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria, J Allergy Clin Immunol, 137, 304, 10.1016/j.jaci.2015.06.004 Vasagar, 2006, Evidence of in vivo basophil activation in chronic idiopathic urticaria, Clin Exp Allergy, 36, 770, 10.1111/j.1365-2222.2006.02494.x Oda, 2019, Low responsiveness of basophils via FcεRI reflects disease activity in chronic spontaneous urticaria, J Allergy Clin Immunol, 7, 2835 Eckman, 2008, Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies, J Invest Dermatol, 128, 1956, 10.1038/jid.2008.55 Lourenco, 2008, Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus, Br J Dermatol, 158, 979, 10.1111/j.1365-2133.2008.08499.x Ferrer, 2003, IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera, Allergy, 58, 802, 10.1034/j.1398-9995.2003.00195.x Haak-Frendscho, 1988, Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release, J Clin Invest, 82, 17, 10.1172/JCI113567 Hide, 1993, Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria, N Engl J Med, 328, 1599, 10.1056/NEJM199306033282204 Niimi, 1996, Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria, J Invest Dermatol, 106, 1001, 10.1111/1523-1747.ep12338544 Kikuchi, 2001, Mechanisms of autoimmune activation of basophils in chronic urticaria, J Allergy Clin Immunol, 107, 1056, 10.1067/mai.2001.115484 Kikuchi, 2002, A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria, J Allergy Clin Immunol, 109, 114, 10.1067/mai.2002.120954 Soundararajan, 2005, Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria, J Allergy Clin Immunol, 115, 815, 10.1016/j.jaci.2004.12.1120 Fiebiger, 1998, Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship, J Clin Invest, 101, 243, 10.1172/JCI511 Cho, 2013, Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders, Ann Allergy Asthma Immunol, 110, 29, 10.1016/j.anai.2012.10.020 Sabroe, 1999, Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-Fcepsilon or anti-IgE autoantibodies, J Allergy Clin Immunol, 2, 484, 10.1016/S0091-6749(99)70475-6 Kolkhir, 2020, Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment, J Allergy Clin Immunol Pract, 8, 318, 10.1016/j.jaip.2019.08.025 Altrichter, 2020, The role of eosinophils in chronic spontaneous urticaria, J Allergy Clin Immunol, 145, 1510, 10.1016/j.jaci.2020.03.005 Peters, 1983, Localization of eosinophil granule major basic protein in chronic urticaria, J Invest Dermatol, 2, 39, 10.1111/1523-1747.ep12538380 Grattan, 1997, Eosinophil major basic protein in autologous serum and saline skin tests in chronic idiopathic urticaria, Br J Dermatol, 2, 132 Ogasawara, 2019, Peptides of major basic protein and eosinophil cationic protein activate human mast cells, Biochem Biophys Rep, 21, 100719 Puccetti, 2005, In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation, Clin Exp Allergy, 35, 1599, 10.1111/j.1365-2222.2005.02380.x Asero, 2020, Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria, Clin Exp Immunol, 200, 242, 10.1111/cei.13428 Shakoory, 2004, The role of human mast cell-derived cytokines in eosinophil biology, J Interferon Cytokine Res, 24, 271, 10.1089/107999004323065057 Lampinen, 2004, Cytokine-regulated accumulation of eosinophils in inflammatory disease, Allergy, 59, 793, 10.1111/j.1398-9995.2004.00469.x Yanase, 2018, Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap formation by the extrinsic coagulating pathway, J Allergy Clin Immunol, 141, 1115, 10.1016/j.jaci.2017.07.026 Saito, 2020, Increase of tissue factor expression on the surface of peripheral monocytes of patients with chronic spontaneous urticaria, Allergy, 75, 971, 10.1111/all.14110 Moosbauer, 2007, Eosinophils are a major intravascular location for tissue factor storage and exposure, Blood, 109, 995, 10.1182/blood-2006-02-004945 Asero, 2006, Plasma of chronic urticaria patients shows signs of thrombin generation and its intradermal injection causes wheal-and-flare reaction much more frequently than autologous serum, J Allergy Clin Immunol, 117, 1113, 10.1016/j.jaci.2005.12.1343 Asero, 2007, Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria, J Allergy Clin Immunol, 119, 705, 10.1016/j.jaci.2006.08.043 Asero, 2008, Severe chronic urticaria is associated with elevated plasma levels of D-dimer, Allergy, 63, 176, 10.1111/j.1398-9995.2007.01514.x Cugno, 2009, Expression of tissue factor by eosinophils in patients with chronic urticaria, Int Arch Allergy Immunol, 148, 170, 10.1159/000155748 Dugina, 2003, Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats, Eur J Pharmacol, 471, 141, 10.1016/S0014-2999(03)01752-7 Ossovskaja, 2004, Protease-activated receptors: contribution to physiology and disease, Physiol Rev, 84, 579, 10.1152/physrev.00028.2003 Yanase, 2021, Coagulation factors induce human skin mast cell and basophil degranulation via activation of complement 5 and the C5a receptor, J Allergy Clin Immunol, 147, 1101, 10.1016/j.jaci.2020.08.018 Suender, 2018, Mast cells are critical for the limitation of thrombin-induced skin inflammation, Exp Dermatol, 27, 50, 10.1111/exd.13407 Tedeschi, 2009, Plasma levels and skin-eosinophil expression of vascular endothelial growth factor (VEGF) in patients with chronic urticaria, Allergy, 64, 1616, 10.1111/j.1398-9995.2009.02069.x Dvorak, 1995, Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, Am J Pathol, 146, 1029 Kamegashira, 2020, Histamine- or vascular endothelial growth factor-induced tissue factor expression and gap formation between vascular endothelial cells are synergistically enhanced by lipopolysaccharide, tumor necrosis factor-alpha, interleukin (IL)-33 or IL-1beta, J Dermatol, 47, 1293, 10.1111/1346-8138.15516 Fujii, 2008, Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy, J Dermatol, 35, 308, 10.1111/j.1346-8138.2008.00474.x Parslew, 2000, Warfarin treatment of chronic idiopathic urticaria and angio-oedema, Clin Exp Allergy, 30, 1161, 10.1046/j.1365-2222.2000.00857.x Chua, 2005, Chronic urticaria responding to subcutaneous heparin sodium, Br J Dermatol, 153, 216, 10.1111/j.1365-2133.2005.06694.x Asero, 2010, Heparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated D-dimer: a pilot study, Int Arch Allergy Immunol, 152, 384, 10.1159/000292947 Bernstein, 2020, Benralizumab for chronic spontaneous urticaria, N Engl J Med, 383, 1389, 10.1056/NEJMc2016395 Sánchez, 1992, Clinicopathological correlation in chronic urticaria, Am J Dermatopathol, 14, 220, 10.1097/00000372-199206000-00007 Sugita, 2000, Correlation between deposition of immuno-components and infiltration pattern of polymorphonuclear leukocytes in the lesions of chronic urticaria, J Dermatol, 27, 157, 10.1111/j.1346-8138.2000.tb02142.x Martins, 2018, Histopathological and clinical evaluation of chronic spontaneous urticaria patients with neutrophilic and non-neutrophilic cutaneous infiltrate, Allergol Int, 67, 114, 10.1016/j.alit.2017.06.012 Grattan, 1990, The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions, Int Arch Allergy Appl Immunol, 93, 198, 10.1159/000235301 Caproni, 2005, Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals, Clin Immunol, 114, 284, 10.1016/j.clim.2004.10.007 Rojanapremsuk, 2015, Clinicopathologic findings in (anti-FcepsilonR1alpha) autoimmune-related chronic urticaria, J Cutan Pathol, 42, 329, 10.1111/cup.12471 Polak, 2019, A novel role for neutrophils in IgE-mediated allergy: evidence for antigen presentation in late-phase reactions, J Allergy Clin Immunol, 143, 1143, 10.1016/j.jaci.2018.06.005 Narla Kay, 2014, Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin, Br J Dermatol, 171, 505, 10.1111/bjd.12991 Tedeschi, 2012, Serum eotaxin levels in patients with chronic spontaneous urticaria, Eur Ann Allergy Clin Immunol, 44, 188 Ying, 1999, Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics, J Immunol, 163, 6321, 10.4049/jimmunol.163.11.6321 Möller, 1993, Human mast cells produce IL-8, J Immunol, 151, 3261, 10.4049/jimmunol.151.6.3261 Kay, 2014, Calcitonin gene-related peptide and vascular endothelial growth factor are expressed in lesional but not uninvolved skin in chronic spontaneous urticaria, Clin Exp Allergy, 44, 1053, 10.1111/cea.12348 Choi, 2008, Neutrophil activation in patients with ASA-induced urticaria, J Clin Immunol, 28, 244, 10.1007/s10875-007-9165-0 Trinh, 2016, Altered systemic adipokines in patients with chronic urticaria, Int Arch Allergy Immunol, 171, 102, 10.1159/000452626 Karaman, 2020, Neutrophil-lymphocyte ratio: a possible marker of remission in children with chronic spontaneous urticaria, Allergol Immunopathol (Madr), 48, 290, 10.1016/j.aller.2019.11.007 Akdogan, 2019, Long-term effects of omalizumab on peripheral blood cells and C-reactive protein levels in patients with chronic spontaneous urticaria, Dermatol Ther, 32, e12966, 10.1111/dth.12966 Önder, 2020, How does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria?, Cutan Ocul Toxicol, 39, 31, 10.1080/15569527.2019.1684316 Rho, 2017, Dynamic regulation of vascular permeability by vascular endothelial cadherin-mediated endothelial cell-cell junctions, J Nippon Med Sch, 84, 148, 10.1272/jnms.84.148 Ito, 2011, Basophil recruitment and activation in inflammatory skin diseases, Allergy, 66, 1107, 10.1111/j.1398-9995.2011.02570.x Zuberbier, 1997, Enhanced P-selectin expression in chronic and dermographic urticaria, Int Arch Allergy Immunol, 114, 86, 10.1159/000237648 Caproni, 2003, Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test, Exp Dermatol, 12, 621, 10.1034/j.1600-0625.2003.00010.x Yosipovitch, 2003, Itch. Lancet, 361, 690, 10.1016/S0140-6736(03)12570-6 Asako, 1994, Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules, J Clin Invest, 93, 1508, 10.1172/JCI117129 Miki, 1996, Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells, Cell Immunol, 171, 285, 10.1006/cimm.1996.0205 Takahagi, 2010, Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria, Allergy, 65, 649, 10.1111/j.1398-9995.2009.02222.x Sakurai, 2015, Increased thrombin generation potential in patients with chronic spontaneous urticaria, Allergol Int, 64, 96, 10.1016/j.alit.2014.07.006 Urano, 2012, Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA, J Biomed Biotechnol, 2012, 208108 Yanase, 2018, Chronic spontaneous urticaria and the extrinsic coagulation system, Allergol Int, 67, 191, 10.1016/j.alit.2017.09.003 van der Kleij, 2005, Significance of conversation between mast cells and nerves, Allergy Asthma Clin Immunol, 1, 65 Borici-Mazi, 1999, Cutaneous responses to substance P and calcitonin gene-related peptide in chronic urticaria: the effect of cetirizine and dimethindene, Allergy, 54, 46, 10.1034/j.1398-9995.1999.00726.x Metz, 2014, Substance P is upregulated in the serum of patients with chronic spontaneous urticaria, J Invest Dermatol, 124, 2833, 10.1038/jid.2014.226 Fowler, 2019, Chronic itch management: therapies beyond those targeting the immune system, Ann Allergy Asthma Immunol, 123, 158, 10.1016/j.anai.2019.01.016 Matsuo, 2018, Neuromedin U directly induces degranulation of skin mast cells, presumably via MRGPRX2, Allergy, 73, 2256, 10.1111/all.13555 Kaplan, 2013, Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy, J Allergy Clin Immunol, 132, 101, 10.1016/j.jaci.2013.05.013 Standler, 2019, Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus, Br J Dermatol, 181, 932, 10.1111/bjd.18025 Elias, 1986, Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T cells, monocytes, and mast cells, J Allergy Clin Immunol, 78, 914, 10.1016/0091-6749(86)90240-X Czarnetzki, 1985, Morphology of the cellular infiltrate in delayed pressure urticaria, J Am Acad Dermatol, 12, 253, 10.1016/S0190-9622(85)80031-1 Chakravarty, 2011, Rituximub successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies, J Allergy Clin Immunol, 128, 1354, 10.1016/j.jaci.2011.08.023 Maurer, 2021, Biologics and the use in chronic spontaneous urticarial: when and which, J Allergy Clin Immunol Pract, 9, 1067, 10.1016/j.jaip.2020.11.043